Adding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure medicine reversed some aspects of breast cancer in the offspring of mice at high risk of the disease because of the high fat diet ...
Dec 30, 2019
0
421
(HealthDay)—Valproic acid and topiramate are confirmed teratogens, according to a study published online June 12 in Neurology.
Jun 13, 2019
0
0
(HealthDay)—Antiepileptic drug (AED) use may increase the risk for pneumonia in patients with Alzheimer disease (AD), according to a study recently published in the Journal of Alzheimer's Disease.
Apr 15, 2019
0
2
People with Alzheimer's disease using antiepileptic drugs have twice the risk of pneumonia compared to non-users, a new study from the University of Eastern Finland shows. The risk was highest in the beginning of use, but ...
Mar 21, 2019
0
0
Expectant mothers often face a dilemma about whether to take medication when they fall ill due to fears it might harm their unborn baby, but new research is unravelling which drugs are safe to take during pregnancy.
Jul 23, 2018
0
5
During pregnancy, use of the antiepileptic drug valproic acid has been associated with worse outcomes—including fetal loss, impaired growth, major congenital malformations, increased risk of developmental problems, and ...
Apr 19, 2018
0
1
Exposure to a compound used to treat migraines and seizures causes characteristics associated with autism, groundbreaking research with zebrafish has demonstrated.
Jan 24, 2018
0
25
Blocking the function of the Ras oncogenes is considered by many scientists to be the "holy grail" of cancer therapeutics because mutations in these genes drive the growth of so many different types of cancers. The three ...
Oct 10, 2017
0
8
(HealthDay)—For patients with epilepsy, anti-epileptic drug serum concentrations remain stable during the ketogenic diet (KD), apart from those of valproic acid, according to a study published online June 18 in the Journal ...
Jun 22, 2017
0
0
(HealthDay)—Concomitant use of valproic acid (VPA) and meropenem (MEPM) is associated with a decrease in VPA plasma levels, according to a study published online Feb. 1 in the Journal of Clinical Pharmacy and Therapeutics.
Feb 9, 2017
0
0
